| Methods |
Randomised controlled trial |
| Participants |
35 participants with a predominantly moderate to severe level of tinnitus‐related distress before treatment were randomly allocated into 1 of 2 treatment groups, corresponding to the 2 stage‐based variations of the Neuromonics Tinnitus Treatment |
| Interventions |
This study evaluates the use of the Neuromonics Tinnitus Treatment ‐ a protocol that incorporates the principle of systematic desensitisation utilising a 12‐month structured rehabilitation programme |
| Outcomes |
The principal outcome measure was the Tinnitus Reaction Questionnaire (TRQ). Pure‐tone audiometry with minimal masking level (MML) and loudness discomfort level (LDL) were also used. These were recorded at 2, 4, 6 and 12 months after instigation of treatment. |
| Notes |
— |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
High risk |
C |
